Yüklüyor......
CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment
Despite the development of targeted therapies and novel inhibitors, cancer remains an undefeated disease. Resistance mechanisms arise quickly and alternative treatment options are urgently required, which may be partially met by drug combinations. Protein kinases as signaling switchboards are freque...
Kaydedildi:
| Yayımlandı: | Pharmaceuticals (Basel) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7760252/ https://ncbi.nlm.nih.gov/pubmed/33255177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120418 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|